Genome wide association studies for diabetes: Perspective on results and challenges

Pediatric Diabetes

Volumn 14, Issue 2, 2013, Pages 90-96

  Torres, Jm ^a   Cox, Nj ^a   Philipson, Lh ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Genetics; Genome wide association studies for diabetes; Type 1 diabetes

Indexed keywords

COPY NUMBER VARIATION; DIABETES MELLITUS; ENVIRONMENTAL FACTOR; EPIGENETICS; EXOME; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; INTRON; NEXT GENERATION SEQUENCING; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI;

EID: 84874503583     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12015     Document Type: Review

References (58)

1. Collins FS, Morgan M, Patrinos A. The Human Genome Project: lessons from large-scale biology. Science 2003: 300: 286-290.
2. International Hapmap Consortium. A haplotype map of the human genome. Nature 2005: 437: 1299-1320.
3. Stranger BE, Stahl EA, Raj T. Progress and promise of genome-wide association studies for human complex trait genetics. Genetics 2011: 187: 367-383.
4. Manolio TA, Collins FS, Cox NJ et al. Finding the missing heritability of complex diseases. Nature 2009: 461: 747-753.
5. Imamura M, Maeda S. Genetics of type 2 diabetes: the GWAS era and future perspectives. Endocr J 2011: 58: 723-739.
6. Sanghera DK, Blackett PR. Type 2 diabetes genetics: beyond GWAS. J Diabetes Metab 2012: 3:5
7. Boomsma D, Busjahn A, Peltonen L. Classical twin studies and beyond. Nat Rev Genet 2002: 3: 872-882.
8. Cui Y, Li G, Li S, Wu R. Designs for linkage analysis and association studies of complex diseases. Stat Methods Mol Biol 2010: 620: 219-242.
9. Nyholt DR. In: Ferreira MAR, Neale BM, Medland SE, Posthuma D, eds. Statistical Genetics: Gene Mapping Through Linkage and Association. Principles of Linkage Analysis. New York, NY: Talylor & Francis Group, 2008: 113-134..
10. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001: 345: 971-980.
11. Castano L, Eisenbarth GS. Type-1 diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 1990: 8: 647-679.
12. Tienari PJ, Tuomilehto-Wolf E, Tuomilehto J et al. HLA haplotypes in type 1 (insulin-dependent) diabetes mellitus: molecular analysis of teh HLA-DQ locus. Diabetologia 1992: 33: 387-395.
13. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 2003: 33: 228-237.
14. Visscher PM, Brown MA, McCarthy MI, Yang J. Five years of GWAS discovery. Am J Hum Genet 2012: 90: 7-24.
15. Wheeler E, Barroso I. Genome-wide association studies and type 2 diabetes. Brief Funct Genomics 2011: 10: 52-60.
16. Zeggini E. A new era for type 2 diabetes genetics. Diabet Med 2007: 24: 1181-1186.
17. Horikawa Y, Oda N, Cox NJ et al. Genetic variation in the gene encoding calpain-10 is associated wit type 2 diabetes mellitus. Nat Genet 2000: 26: 163-175.
18. Reynisdottir I, Thorleifsson G, Benediktsson R et al. Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2. Am J Hum Genet 2003: 73: 323-335.
19. Grant SF, Thorleifsson G, Reynisdottir I et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006: 38: 320-323.
20. Groves CJ, Zeggini E, Minton J et al. Association analysis of 6, 736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes 2006: 55: 2640-2644.
21. Zhang C, Qi L, Hunter DJ et al. Vriant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of U.S. women and men. Diabetes 2006: 55: 2645-2648.
22. van der Sluis S, Posthuma D. Single-locus association models. In: Ferreira MAR, Neale BM, Medland SE, Posthuma D, eds. Statistical Genetics: Gene Mapping Through Linkage and Association. New York, NY: Taylor & Francis Group, 2008: 323-354..
23. Jorgensen TJ, Ruczinski I, Bailey K, Smith MW, Shugart YY, Alberg AJ. Hypothesis-driven candidate gene association studies: practical design and analytical considerations. Am J Epidemiol 2009: 170: 986-993.
24. Altshuler D, Hirschhorn JN, Klannemark M et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000: 26: 76-80.
25. Gloyn AL, Weedon MN, Owen KR et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 2003: 52: 568-572.
26. Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H. Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance--a population-based twin study. Diabetologia 1999: 42: 139-145.
27. Groop L, Forsblom C, Lehtovirta M et al. Metabolic consequences of a familiy history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 1996: 45: 1585-1593.
28. Manolio TA, Collins FS. The HapMap and genome-wide association studies in diagnosis and therapy. Annu Rev Med 2009: 60: 443-456.
29. Gabriel SB, Schaffner SF, Nguyen H et al. The structure of haplotype blocks in the human genome. Science 2002: 296: 2225-2229.
30. Weir BS. Genetic data analysis II: methods for discrete population genetic data. 2nd edn. Sunderland, MA: Sinauer Associates Inc, 1996.
31. Hinds DA, Stuve LL, Nilsen GB et al. Whole-genome patterns of common DNA variation in three human populations. Science 2005: 307: 1072-1079.
32. Spencer CCA, Su Z, Donnelly P, Marchini J. Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip. PLoS Genet 2009: 5: e1000477.
33. Amos CI. Successful design and conduct of genome-wide association studies. Hum Mol Genet 2007: 16: R220-R225.
34. Sladek R, Rocheleau G, Rung J. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007: 445: 881-885.
35. Zeggini E, Weedon MN, Lindgren CM. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007: 316: 1336-1341.
36. Scott LJ, Mohlke KL, Bonnycastle LL. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007: 316: 1341-1345.
37. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007: 316: 1331-1336.
38. Chimienti F, Devergnas S, Favier A, Seve M. Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes 2004: 53: 2330-2337.
39. Billings LK, Florez JC. The genetics of type 2 diabetes: what have we learned from GWAS? Ann N Y Acad Sci 2010: 1212: 59-77.
40. Prokopenko I, Langenberg C, Florez JC. Variants in MTNR1B influence fasting glucose levels. Nat Genet 2009: 41: 77-81.
41. Dupuis J, Langenberg C, Prokopenko I. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010: 42: 105-116.
42. Kathiresan S, Willer CJ, Peloso GM. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 2009: 41: 56-65.
43. Freathy RM, Mook-Kanamori DO, Sovio U. Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight. Nat Genet 2010: 42: 430-435.
44. Petrie John R, Pearson ER, Sutherland C. Implications of genome wide association studies for the understanding of type 2 diabetes pathophysiology. Biochem Pharmacol 2011: 81: 471-477.
45. Johansson S, Irgens H, Chudasama KK et al. Exome sequencing and genetic testing for MODY. PLoS One 2012: 7: e38050.
46. Palmer ND, McDonough CW, Hicks PJ et al. A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One 2012: 7: e29202.
47. Ryu J, Lee C. Association of glycosylated hemoglobin with the gene encoding CDKAL1 in the Korean Association Resource (KARE) study. Hum Mutat 2012: 33: 655-659.
48. Meigs JB, Shrader P, Sullivan LM et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 2008: 359: 2208-2219.
49. Lyssenko V, Jonsson A, Almgren P. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 2008: 359: 2220-2232.
50. Cirulli Elizabeth T, Goldstein DB. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 2010: 11: 415-425.
51. Kang HM, Gaulton K, Voight BF et al. Sequencing and genotyping thousands of European genomes and exomes to better understand the genetic architecture of type 2 diabetes: the Go T2D Study. International Congress of Human Genetics 2011. Montreal, Canada.
52. Mohlke KL, Scott LJ. What will diabetes genomes tell us? Curr Diab Rep 2012: 12: 643-650.
53. Almeida M, Jun G, Teslovich TM et al. Whole genome sequencing to discover type 2 diabetes risk genes in Mexican American pedigrees: T2D-GENES consortium project 2 in American Diabetes Association 72nd Scientific Sessions. 2012. Philadelphia, PA.
54. Purcell S, Neale B, Todd-Brown K et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007: 81: 559-575.
55. Elbein SC, Gamazon ER, Das SK, Rasouli N, Kern PA, Cox NJ. Genetic risk factors for type 2 diabetes: a trans-regulatory genetic architecture? Am J Hum Genet 2012: 91: 466-477.
56. Nicolae DL, Gamazon E, Zhang W, Duan S, Eileen Dolan M, Cox NJ. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet 2010: 6: 1-10.
57. Below JE, Gamazon ER, Morrison JV et al. Genome-wide association and meta-analysis in populations from Starr County, Texas, and Mexico City identify type 2 diabetes susceptibilty loci and enrichment for expression quantitative trait loci in top signals. Diabetologia 2011: 54: 2047-2055.
58. Parra EJ, Below JE, Escobedo J et al. Genome-wide association study of type 2 diabetes in a sample from Mexico City and a meta-analysis of a Mexican-American smaple from Starr County, Texas. Diabetologia 2011: 54: 2038-2046.